Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06158581

Comparing Two Different Emotion Therapies for Autistic Youth and Young Adults

Too few clinicians are able and willing to help autistic patients. A recent review identified challenges to mental health service delivery in autism, including a lack of interventions designed for community implementation and limited workforce capacity. It has been argued that improving impairment in emotion regulation has the potential to improve a range of mental health difficulties in autistic people. In this clinical trial, the investigators are comparing two evidence-based interventions for emotion regulation, to determine if one created specifically for autistic people is clinically superior. The interventions will be implemented in the community, through partnering agencies.

Recruiting

Interested in participating?

Request Info

Key information

Age range

10 year–30 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

University of Alabama, Tuscaloosa, Alabama, United States

Loading trial locations.

About this study

This study will compare the effectiveness of two transdiagnostic interventions for autistic adolescents and young adults - an intervention in widespread use among non-autistic populations (The Unified Protocol; UP) versus an autism-specific intervention (The Emotion Awareness and Skills Enhancement Program; EASE). The UP and EASE are ideal comparators because they are structurally equivalent and transdiagnostic - both shown to improve mental health outcomes that stakeholders identify as important, such as depression, irritability, and anxiety. The investigators will partner with 12 different community clinics in Pennsylvania and Alabama to recruit participants and facilitate the interventions. Each clinic will be randomized to use either UP or EASE. The investigators will look at effectiveness of the treatments, as well as the feasibility, benefits and harms.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • professional diagnosis of ASD
  • a score in the clinical range on the EDI-Reactivity or EDI-Dysphoria scale based on caregiver report or self-report
  • The study is open to people with a range of communication abilities. Participants must be able to consent to the study themselves and answer questions about themselves.
  • Participants need to have a support person that could answer questions about them too. This could be a parent, caregiver, family member, partner or friend. Independent adults can opt out of this portion.
  • Participants must live in Alabama or Pennsylvania.

Exclusion criteria

  • Higher level of care is needed (Imminent Suicide / Homicide Threat, acute psychosis, mania)

Treatment and study plan

The Emotion Awareness and Skills Enhancement Program

Behavioral

EASE is a cutting-edge program created by researchers at the University of Alabama and the University of Pittsburgh in collaboration with autistic individuals, caregivers of autistic youth, and therapists. The overarching goal of the program is to support autistic clients who want to work on emotion regulation. EASE is unique because it targets emotional distress in autistic youth and adults, instead of targeting the core symptoms of autism (i.e., it is not a social skills intervention).

The program is a 16-session, mindfulness-based intervention. Each session is 1:1 for 45 minutes to one hour. While the program is designed for individual intervention, caregivers are also invited to play an active role on the care team.

Other names: EASE

The Unified Protocol

Behavioral

UP is a thoroughly-studied, manualized intervention created by researchers at the University of Miami in conjunction with researchers at Boston University. The program was designed to be customizable to meet the needs of people with a variety of diagnoses, allowing more individuals to access emotion regulation resources. The protocol also has different modules to accommodate different developmental levels (UP-Children, UP-Adolescent, UP-Adult). The overall goal of UP is to help clients identify emotions and build new strategies to cope with stressful life situations and distressing emotions.

The protocol is flexible, with each session is about 45 to 60 minutes and the number of sessions varying between 12 - 21 sessions. For the current study, the treatment will take place over 16 sessions. The intervention is cognitive behavioral therapy (CBT) based but also includes hints of mindfulness-based intervention strategies.

Other names: UP

Primary outcomes

  1. Emotion Dysregulation Inventory

    Time frame: Baseline, Midpoint (after completing 8 sessions), Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    The EDI does not have a single overall score. It is comprised of two scales: Reactivity and Dysphoria. Items are on a 0 to 4 scale, where 0 is Never happens and 4 is Almost always happens or causes a serious problem. There are clinical cutoffs for both scales.

  2. Weiner's Acceptability, Appropriateness, & Feasibility of Intervention Scales

    Time frame: Baseline and Post treatment of first client (after all 16 sessions, average 16-20 weeks)

    Weiner's is a widely used 12-item battery of three scales assessing intervention acceptability, appropriateness, and feasibility with strong psychometric properties. There is a 1 to 5 scale, where 1 is Completely disagree and 5 is Completely agree. Higher scores indicate greater acceptability, appropriateness, and feasibility.

  3. Provider Self-Efficacy Scale

    Time frame: Baseline and Post trial (4 years)

    It assesses both knowledge (of protocol) and confidence (in one's ability to implement as intended). It is a 0-10 scale, where 0 is not at all confident and 10 is extremely confident. Higher scores indicate higher confidence.

Secondary outcomes

  1. Clinical Global Impressions

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks)

    The CGI will be used as a measure of overall improvement. The CGI was designed to measure overall symptomatic change at a specific time as compared to baseline that is completed by a rater who is blind to treatment assignment. Scores range from 1 (Very Much Improved) to 4 (Unchanged) to 7 (Very Much Worse). It is only a single item, and lower scores indicate more improvement.

  2. PROMIS Depression

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    It is a brief, change sensitive 8 item measure. It is a 1-5 scale, where 1 is Never and 5 is Always.

  3. PROMIS Anxiety

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    It is a brief, change sensitive 8 item measure. It is a 1-5 scale, where 1 is Never and 5 is Always.

  4. Buss-Perry Aggression Questionnaire

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    27-item self-report measure of general aggression, physical aggression, verbal aggression, anger, and hostility. It is a 1-7 scale, where 1 is Extremely uncharacteristic of me and 7 is Extremely characteristic of me.

  5. Emotion Regulation Questionnaire for Children and Adolescents

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    ERQ-CA has10 items that comprise of two scales: cognitive reappraisal use and expressive suppression, which are two regulatory strategies considered adaptive and protective in terms of mental health. It is a 1-7 scale, where 1 is Strongly disagree and 7 is Strongly agree.

  6. Child & Adolescent Mindfulness Measure

    Time frame: Baseline, Midpoint (after completing 8 sessions), Post treatment (after all 16 sessions, average 16-20 weeks)

    CAMM is a 10-item self-report measure of mindfulness. It is a 0-4 scale, where 0 is Never true and 4 is Always true. When scoring, you reverse all scores (i.e. 0 to 4) and then sum. Higher scores correspond to higher levels of mindfulness.

  7. WHO Quality of Life-BREF-ID

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    WHOQoL-BREF-ID is a simplified version of the World Health Organization Quality of Life. It has a 3 or 5 point visual response scale, where 1 is Not at all and 5 is Totally.

  8. Satisfaction with Life Scale

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks)

    Satisfaction was Life Scale is a 5-item measure of global life satisfaction. It is a 1-7 scale, where 1 is Strongly disagree and 7 is Strongly agree.

  9. Self-Compassion Scale-Youth Version

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    Self-Compassion Scale - Youth Version consists of 17 self-report items ranked on a 5-point Likert scale, yielding six subscales (self-kindness, self-judgment, common humanity, isolation, mindfulness, over-identification) and an overall score. 1 is Almost Never and 5 Almost Always.

  10. Relationships, Employment, Autonomy, and Life Satisfaction

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks)

    REALS Measures are a compilation of scales tapping many areas of adult life. Each scale is scored independently and should be utilized as different sources of information. It does not produce a global outcome score. With the frequency scales, it is a 0-4 scale where 0 is Never and 4 is Always.

  11. AASPIRE Flourishing Scale

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    It is 9 item scale that assesses aspects of life satisfaction for autistic individuals. It is a scale from strongly disagree to strongly agree.

  12. AASPIRE Burnout Scale Short Form

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    It is a 14-item self-report measure of autistic burnout. It is a scale from strongly disagree to strongly agree.

  13. Credibility and Expectancy Questionnaire

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks)

    It will assess treatment expectancy and rationale for the assessed treatments.

  14. AASPIRE Patient Health Questionnaire-9

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    This is a 9-item self-report questionnaire for screening, diagnosing, monitoring and measuring the severity of depression, that includes an item that is widely utilized as an index of suicidal ideation severity. Each item is rated on a scale from Rarely or not at all to Almost every day. Higher scores would relate to higher depression.

  15. Inventory of Statements about Self-Injury

    Time frame: Baseline, Post treatment (after all 16 sessions, average 16-20 weeks), 3 months following post-treatment

    ISAS is a continuous self-report measure of self-injurious behaviors. It is the most commonly used measure of self-injury. Higher numbers in Section 1 would indicate more self-injurious behaviors.

  16. Working Alliance Inventory

    Time frame: Midpoint (after completing 8 sessions, average 8 weeks), After completing 15 sessions (average 15-19 weeks)

    WAI is a clinician-report measure assessing the therapeutic alliance between the client/participant and the clinician. The measure is 12 items, rated on a 5-point scale.

  17. Vanderbilt Therapeutic Alliance Scales Revised, Short Form

    Time frame: 2 randomized timepoints over up to 20 Weeks

    VTAS-R-SF is an observational measure of alliance and consists of five items to capture the strength of the perceived support and trust, participation, and agreement on tasks and goals between client and therapist. Each item is rated 0-5, and higher scores mean more alliance. The measure is used for coding videos or audio files of the therapy sessions. It will be completed twice with each participant but the timepoint is randomized (one randomized session from the first half of therapy and one randomized session from the second half of therapy).

  18. Child Involvement Rating Scale

    Time frame: 2 randomized timepoints over up to 20 Weeks

    Child Involvement Rating Scale is a 10-item, 6-point observational scale to rate involvement and engagement during therapy. The first 6 items rate positive involvement where 0 is not at all and 5 is a great deal. The last 4 items rate negative involvement where 0 is not at all and 5 is a great deal. The measure is used for coding videos or audio files of the therapy sessions. The measure will be completed twice with each participant but the timepoint is randomized (one randomized session from the first half of therapy and one randomized session from the second half of therapy).

Study contacts

Contact information is provided by the study sponsor or research team.

Kara Duman, MSW

CONTACT

[email protected]

1-866-647-3436

Madison Bradley

CONTACT

[email protected]

205-348-2472

Sponsors and collaborators

Lead sponsor

University of Pittsburgh

Other

Collaborators

  • Patient-Centered Outcomes Research Institute
  • University of Alabama, Tuscaloosa

Registry information

Official study title

The Emotion Awareness and Skills Enhancement (EASE) Program Versus the Unified Protocol (UP)

Important dates

Study start
2024
Primary completion
2027
Study completion
2027
First posted
Dec 6, 2023
Registry last updated
Apr 13, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.